Definition of drug resistant epilepsy: Consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies
Tóm tắt
To improve patient care and facilitate clinical research, the International League Against Epilepsy (ILAE) appointed a Task Force to formulate a consensus definition of drug resistant epilepsy. The overall framework of the definition has two “hierarchical” levels: Level 1 provides a general scheme to categorize response to each therapeutic intervention, including a minimum dataset of knowledge about the intervention that would be needed; Level 2 provides a core definition of drug resistant epilepsy using a set of essential criteria based on the categorization of response (from Level 1) to trials of antiepileptic drugs. It is proposed as a testable hypothesis that drug resistant epilepsy is defined as failure of adequate trials of two tolerated, appropriately chosen and used antiepileptic drug schedules (whether as monotherapies or in combination) to achieve sustained seizure freedom. This definition can be further refined when new evidence emerges. The rationale behind the definition and the principles governing its proper use are discussed, and examples to illustrate its application in clinical practice are provided.
Từ khóa
Tài liệu tham khảo
Arzimanoglou A, 2008, Progress in Epileptic Disorder (Volume 7): Drug‐resistant epilepsies, 1
Hanley JA, 1983, If nothing goes wrong, is everything alright?, JAMA, 259, 1743, 10.1001/jama.1983.03330370053031
Kahane P, 2008, Drug‐resistant Epilepsies. Progress in Epileptic Disorders
Kwan P, 2006, The Treatment of Epilepsy: Principles and Practice, 983
World Health Organization, 1972, International Drug Monitoring: the Role of National Centres, 498
World Health Organization Collaborating Centre for Drug Statistics Methodology. (2008)About the ATC/DDD system. Accessed December 1 2008 athttp://www.whocc.no/atcddd/.